Paying users zone. Data is hidden behind hidden.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Verified by Visa MasterCard SecureCode American Express SafeKey

This is a one-time payment. There is no automatic renewal.

Microsoft Excel LibreOffice Calc

Pfizer Inc. (PFE)


Common-Size Balance Sheet: Liabilities and Stockholders’ Equity

Beginner level

Pfizer Inc., common-size consolidated balance sheet: liabilities and stockholders’ equity

Microsoft Excel LibreOffice Calc
Dec 31, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 31, 2014
Short-term borrowings, including current portion of long-term debt hidden hidden hidden hidden hidden
Trade accounts payable hidden hidden hidden hidden hidden
Dividends payable hidden hidden hidden hidden hidden
Income taxes payable hidden hidden hidden hidden hidden
Accrued compensation and related items hidden hidden hidden hidden hidden
Other current liabilities hidden hidden hidden hidden hidden
Liabilities held for sale hidden hidden hidden hidden hidden
Current liabilities hidden hidden hidden hidden hidden
Long-term debt, excluding current portion hidden hidden hidden hidden hidden
Pension benefit obligations, net hidden hidden hidden hidden hidden
Postretirement benefit obligations, net hidden hidden hidden hidden hidden
Noncurrent deferred tax liabilities hidden hidden hidden hidden hidden
Other taxes payable hidden hidden hidden hidden hidden
Other noncurrent liabilities hidden hidden hidden hidden hidden
Noncurrent liabilities hidden hidden hidden hidden hidden
Total liabilities hidden hidden hidden hidden hidden
Preferred stock, no par value, at stated value hidden hidden hidden hidden hidden
Common stock, $0.05 par value hidden hidden hidden hidden hidden
Additional paid-in capital hidden hidden hidden hidden hidden
Treasury stock, shares at cost hidden hidden hidden hidden hidden
Retained earnings hidden hidden hidden hidden hidden
Accumulated other comprehensive loss hidden hidden hidden hidden hidden
Total Pfizer Inc. shareholders’ equity hidden hidden hidden hidden hidden
Equity attributable to noncontrolling interests hidden hidden hidden hidden hidden
Total equity hidden hidden hidden hidden hidden
Total liabilities and equity hidden hidden hidden hidden hidden

Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27).

Balance sheet item Description The company
Current liabilities Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Pfizer Inc.’s current liabilities as a percentage of total liabilities and equity decreased from 2016 to 2017 but then increased from 2017 to 2018 exceeding 2016 level.
Noncurrent liabilities Amount of obligation due after one year or beyond the normal operating cycle, if longer. Pfizer Inc.’s noncurrent liabilities as a percentage of total liabilities and equity decreased from 2016 to 2017 and from 2017 to 2018.
Total liabilities Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future. Pfizer Inc.’s total liabilities as a percentage of total liabilities and equity decreased from 2016 to 2017 but then slightly increased from 2017 to 2018.
Total Pfizer Inc. shareholders’ equity Total of all stockholders’ equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity’s stockholders’ equity attributable to the parent excludes the amount of stockholders’ equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Pfizer Inc.’s total Pfizer Inc. shareholders’ equity as a percentage of total liabilities and equity increased from 2016 to 2017 but then slightly decreased from 2017 to 2018.